Technology

RSS

Breeders and biotech companies are hoping for regulatory elbow room as the EU and other nations pursue oversight rules for gene editing techniques.

Researchers in the U.S. and abroad are reporting progress on eliminating Porcine Reproductive and Respiratory Syndrome (PRRS), an incurable pig disease that costs the American pork industry as much as $660 million per year. However, regulatory hurdles and consumer perceptions are slowing down the commercialization of a possible cure through gene editing.

Reorganization plans at the Departments of Interior and Energy did not get a warm reception at the Senate Energy and Natural Resources Committee last week, with senators particularly concerned about the administration's proposal to eliminate the Advanced Research Projects Agency within the Department of Energy (ARPA-E).